雜志介紹

Journal Of Oncology雜志介紹

《Journal Of Oncology》是一本以English為主的開放獲取國際優(yōu)秀期刊，中文名稱腫瘤學(xué)雜志，本刊主要出版、報(bào)道醫(yī)學(xué)-ONCOLOGY領(lǐng)域的研究動(dòng)態(tài)以及在該領(lǐng)域取得的各方面的經(jīng)驗(yàn)和科研成果，介紹該領(lǐng)域有關(guān)本專業(yè)的最新進(jìn)展，探討行業(yè)發(fā)展的思路和方法，以促進(jìn)學(xué)術(shù)信息交流，提高行業(yè)發(fā)展。該刊已被國際權(quán)威數(shù)據(jù)庫SCIE收錄，為該領(lǐng)域相關(guān)學(xué)科的發(fā)展起到了良好的推動(dòng)作用，也得到了本專業(yè)人員的廣泛認(rèn)可。最新CiteScore 指數(shù)為3.9。

本刊近期中國學(xué)者發(fā)表的論文主要有：

• Prognostic Value of a CT Radiomics-Based Nomogram for the Overall Survival of Patients with Nonmetastatic BCLC Stage C Hepatocellular Carcinoma after Stereotactic Body Radiotherapy

  Author: Wang, Lihong; Yan, Danfang; Shen, Liang; Xie, Yalin; Yan, Senxiang

• Histone Deacetylase 1 Expression and Regulatory Network in Lung Adenocarcinoma Based on Data Mining and Implications for Targeted Treatment

  Author: Zhong, Yueyuan; Li, Mingdong; Guo, Shihui; Li, Minhua; Cao, Zitong; Luo, Xueyao; Liu, Jianhong; Liang, Runzhang; Shao, Yingqi; Yang, Yue; Chen, Xinqia; Wei, Chuzhong; Ling, Weijun; Zhu, Xiao; Huang, Yongmei

• Cell-Free DNA in Cerebrospinal Fluid Complements the Monitoring Value of Interleukin-10 in Newly Diagnosed Primary Central Nervous System Lymphoma

  Author: Wang, Wei; Zou, DongMei; Zhuang, Zhe; Zhang, Xiao; Zhang, Li; Yin, JingJing; Jia, CongWei; Yuan, Li; Cai, Hao; Zhang, Yan; Wang, Xuan; Zhang, MeiFen; Zhou, DaoBin; Zhang, Wei

• Activated Mast Cells Combined with NRF2 Predict Prognosis for Esophageal Cancer

  Author: Guo, Xinxin; Shen, Weitao; Sun, Mingjun; Lv, Junjie; Liu, Ran

英文介紹

Journal Of Oncology雜志英文介紹

Journal of Oncology is a peer-reviewed, Open Access journal that publishes original research articles, review articles, and clinical studies related to breast cancer, lung cancer, gastrointestinal cancer, skin cancer, head and neck cancer, paediatric oncology, neurooncology as well as genitourinary cancer. The journal provides a multidisciplinary forum for translational and clinical oncology research in the areas of molecular pathology, genomics, diagnosis and therapy, with a specific focus on molecular targeted agents and novel immune therapies.